InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Zdanowski Michael, Chief Technology Officer. Director active across 1 companies, notably Talaris Therapeutics, Inc.. In total, 2 disclosures have been published. The latest transaction was disclosed on 31 December 2021 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€16,8741,470 shares@ €11.479100.0% of flow
Common Stock
SEC:0000899243-22-004200·
€16,8741,470 shares@ €11.47950.0% of flow
Common Stock
SEC:0000899243-22-004200:0·
2 of 2 declarations
About Zdanowski Michael
Michael Zdanowski is Chief Technology Officer at Talaris Therapeutics, Inc. He is responsible for the technological direction of the company, overseeing the development and implementation of innovative solutions. His technical expertise is crucial for advancing the organization's projects.
